Effect of Combined Low Dose Human Gonadotropic Hormone, Follicle Stimulating Hormone, and Testosterone Therapy (LFT Regimen) Versus Conventional High Dose Human Gonadotropic Hormone and Follicle Stimulating Hormone on Spermatogenesis and Biomarkers in Men With Hypogonadotropic Hypogonadism
EndocrinologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
- Publicado em
- 25 jul 2024
- Citações
- 3
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Effect of Combined Low Dose Human Gonadotropic Hormone, Follicle Stimulating Hormone, and Testosterone Therapy (LFT Regimen) Versus Conventional High Dose Human Gonadotropic Hormone and Follicle Stimulating Hormone on Spermatogenesis and Biomarkers in Men With Hypogonadotropic Hypogonadism
Nikhil Singhania, Konsam Biona Devi, Japleen Kaur, Anil Bhansali, Ujjwal Gorsi, Naresh Sachdeva, Sunil Arora, Ashutosh Rai, Rama Walia
Descritores MeSH
- Spermatogenesis
- Testosterone
- Biomarkers
- Follicle Stimulating Hormone
- Hypogonadism
- Male
- Pilot Projects
- Anti-Mullerian Hormone
- Adult
- Young Adult